Device registries are evolving into critical infrastructure for long-term outcome tracking, real-world evidence generation, and regulatory decision-making under MDR. However, their impact depends on resolving persistent issues around data quality, standardisation, and governance.

Apple and WHOOP are taking two starkly different paths toward blood pressure monitoring. Their divergence underscores how design, intent, and evidence define whether wearables are wellness tools or medical devices.

Technology-grade grown diamonds (TGGD) are emerging as a high-performance material in MedTech. While the benefits are significant, challenges around manufacturability, cost, and regulatory validation must be addressed before widespread adoption.

Regulatory clearance is the starting point for commercial execution. Companies that delay go-to-market planning, hiring, and channel strategy often struggle to scale despite approval. Sustainable growth comes from building a revenue engine in parallel with regulatory progress and refining it…

Sterile services are essential to patient safety, yet UK training still focuses on procedures over purpose, relies on outdated methods. Global evidence shows that modern, learner-centred approaches, such as mobile and modular training, reduce errors and improve staff performance. Without…

ISO 22301 provides a globally recognised framework for identifying critical operations, assessing risks, and ensuring rapid, coordinated recovery from disruptions. Organisations that adopt ISO 22301 strengthen operational resilience, meet regulatory expectations, and gain competitive advantage by demonstrating preparedness, reliability, and…

Biological implants made from animal tissues offer a low-cost, abundant, and biomechanically superior alternative to synthetic implants. They integrate naturally with patient tissue, reduce infection risk, and avoid immune rejection, although manufacturers face regulatory, size, and cleanroom production challenges. With…